VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
KYNB
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
HomeStocksKYNBInstitutional Holders

KYNB logoKyntra Bio, Inc. (KYNB) Institutional Ownership

Q2 2026 13F Data|Updated 2026-11-18

✨

Institutional ownership decreased this quarter (-0.89 pp), while top 10 holders maintain a highly concentrated 96.1% of value.

Institutional Ownership
Can exceed 100% due to securities lending, short interest, and reporting timing differences.
26.9%$7M total value · ▼ 0.89 pp vs prior quarter
Smart Money Score
Based on ownership concentration, fund quality, buying/selling activity, ownership indicators, and institutional trend.
42 / 100Neutral
Institutions & Flow29 holders-4 net flow (+1 / -5)

AI Insights & Key Takeaways

  • Negative Institutional Flow (-4)
  • Marquee funds including Susquehanna International Group, Llp and Two Sigma Investments, Lp maintain significant positions
  • Top 10 holders control 96.1% of institutional value
  • No Insider Signal

Top Institutional Holders of KYNB

Ranked by reported Q2 2026 13F market value

Top 10 Holders
96.1%
Top 25 Holders
100.0%

Share of total reported institutional value in KYNB held by the largest 10 / 25 filers.

#InstitutionShares HeldMarket ValueQoQ ChangeOwnership %% of Fund
1ARMISTICE CAPITAL, LLC400K$3.0M0.0%9.879%0.04%
2VANGUARD CAPITAL MANAGEMENT LLC160K$1.2M+2.1%3.950%0.00%
3

Quarterly Institutional Activity

Filings activity in KYNB during Q2 2026, grouped by how each filer changed its position.

OverviewNew Buyers1Added To24Trimmed2Exited5
  • TWO SIGMA INVESTMENTS, LP$298K
  • UBS Group AG$59K

KYNB Institutional Ownership by Quarter

8 quarters of 13F filings · Δ columns show change vs prior quarter

QuarterInst. HoldersΔ HoldersOwnership %Δ OwnershipTotal 13F ValueΔ Value
Q2 20262915%26.88%0.89 pp$7M+5.7%
Q1 202634+3.0%27.77%—$7M39%
Q4 202533+0.0%——$11M29%
Q3 202533+22%——$16M+233%
Q2 20252752%——$5M47%
Q1 20255619%1.16%

How KYNB Compares to Peers

Institutional ownership and quarterly buying activity across the largest Oncology Biotech peers.

TickerCompanyMarket CapInst. OwnershipHoldersNet Buyers − Sellers
DMRADamora Therapeutics, Inc.$1.46B200.0%99+33
FTHFaeth Therapeutics, Inc.$568M54.5%45+16
LONALeonaBio, Inc.$17M184.4%45+4
CNSYCerenome, Inc.$5M4.8%24-5
NXTSNexentis Technologies Inc.$291013.3%9-1

KYNB — Frequently Asked Questions

Quick answers to the most common questions about buying KYNB stock.

What percentage of KYNB is owned by institutions?

Based on Q2 2026 13F filings, institutional ownership of Kyntra Bio, Inc. stands at 26.9%, held across 29 reporting institutions.

Who is the largest institutional holder of KYNB?

ARMISTICE CAPITAL, LLC is the largest reported institutional holder of KYNB, with approximately 400,000 shares worth $0.00B as of Q2 2026.

Is KYNB a hedge fund favorite?

Yes — 3 widely-followed marquee investors appear among the top 25 institutional holders of KYNB, including SUSQUEHANNA INTERNATIONAL GROUP, LLP, TWO SIGMA INVESTMENTS, LP, RENAISSANCE TECHNOLOGIES LLC.

What is KYNB's Smart Money Score?

Our composite Smart Money Score for KYNB is 42 out of 100 (Neutral). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.

How many institutions bought KYNB this quarter?
SUSQUEHANNA INTERNATIONAL GROUP, LLP
89K
$675K
0.0%
2.208%
0.00%
4BlackRock, Inc.84K$637K0.0%2.083%0.00%
5GEODE CAPITAL MANAGEMENT, LLC43K$326K-6.0%1.067%0.00%
6HighTower Advisors, LLC40K$300K+0.0%0.982%0.00%
7TWO SIGMA INVESTMENTS, LP40K$298K-20.2%0.976%0.00%
8RENAISSANCE TECHNOLOGIES LLC27K$204K-1.5%0.669%0.00%
9VANGUARD FIDUCIARY TRUST CO24K$182K+0.7%0.595%0.00%
10Birchview Capital, LP23K$170K0.0%0.557%0.08%
11STATE STREET CORP20K$153K0.0%0.501%0.00%
12UBS Group AG8K$59K-71.5%0.194%0.00%
13GROUP ONE TRADING LLC4K$33K-1.9%0.109%0.00%
14Vanguard Global Advisers, LLC1K$11K0.0%0.035%0.00%
15Tower Research Capital LLC (TRC)1K$8K+235.2%0.028%0.00%
16Axiom Investment Management LLC704$5K0.0%0.017%0.00%
17MORGAN STANLEY487$4K-0.2%0.012%0.00%
18HARBOUR INVESTMENTS, INC.200$2K0.0%0.005%0.00%
19NATIONAL BANK OF CANADA /FI/193$1K0.0%0.005%0.00%
20OSAIC HOLDINGS, INC.182$1K+1.1%0.005%0.00%
21Nova Financial LLC160$1K0.0%0.004%0.00%
22SBI Securities Co., Ltd.152$1K0.0%0.004%0.00%
23ROYAL BANK OF CANADA138$1K+0.7%0.003%0.00%
24ACADIAN ASSET MANAGEMENT LLC106K$7950.0%2.608%0.00%
25BNP PARIBAS FINANCIAL MARKETS46$347-8.0%0.001%0.00%

denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in KYNB — a direct measure of their conviction.

0.12 pp
$9M
47%
Q4 2024692.8%1.28%145.63 pp$17M99%
Q3 202471—146.91%—$1.48B—

Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.

1 institutions opened new positions in KYNB during Q2 2026, while 5 fully exited. 24 added to existing positions and 2 trimmed.

How is institutional ownership of KYNB changing?

KYNB institutional ownership fell by 0.89 percentage points quarter-over-quarter, with a net change of -5 holders.

How concentrated is KYNB ownership among the top holders?

The top 10 institutions account for 96.1% of all reported 13F value in KYNB, and the top 25 account for 100.0%.

How does KYNB compare to Oncology Biotech on institutional ownership?

Across the largest Oncology Biotech peers, institutional ownership levels are: DMRA (200.0%), FTH (54.5%), LONA (184.4%), CNSY (4.8%), NXTS (3.3%). See the peer comparison table on this page for net buyer activity by company.

Where does this KYNB institutional ownership data come from?

All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.

KYNBKyntra Bio, Inc.
$2.04$15M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership